A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Dhatturadi Taila as compared to the efficacy of Vipadikahar Ghrita Taila in Vipadika.

Current management strategies for palmoplantar psoriasis involve topical treatments (corticosteroids), Phototherapy

• Psoralen And Ultraviolet A (PUVA), systemic immunomodulators (Ciclosporin, Azathioprine, Methotrexate, etc), and biologic agents (Infliximab, Ustekinumab, etc), however, these approaches often come with limitations like a relapse of the skin lesions after discontinuing the treatment, the potential to create skin cancer, melanomas, high cost, and potential immunosuppressive side effects.

Acharya Sushruta has mentioned Kushta as one of the complications of Dooshivisha. Hence, an effort is needed to look for Dooshivisha hetu among patients with Kushta with special reference to Vipadika.

Hence, this is an effort to evaluate the efficacy of the external application of Dhatturadi Taila for chronic skin conditions such as Vipadika in a Controlled Clinical Trial along with Dooshivisha hetu among the patients with vipadika.